REGENHU-Switzerland-3d-bioprinting-instrument-bio-3d-bioprinter-ManagementTeam-0002
RESET
04.02.2021
REGENHU-Switzerland-3d-bioprinting-solutions-bio-3d-printers-FLAMINGOProject-PersonalizedMedicine-Rheumatoid-Arthritis
04.02.2021
News, Media Releases

REGENHU announces its participation in the FLAMIN-GO project aimed at developing “personalized” treatments against Rheumatoid Arthritis

Villaz-St-Pierre, Switzerland
REGENHU today announced its participation in the FLAMIN-GO research project aimed at developing an organ-on-chip technology for clinical trials on Rheumatoid Arthritis (RA). FLAMIN-GO is a EU-funded project featuring a strong, well-balanced composition of hospital, academia and industry partners which brings together the know-how of experts in the fields of rheumatology, material science, tissue engineering, […]
09.11.2020
REGENHU-USA-Minneapolis-3d-bioprinting-Solutions -bio-3d-printers-fresh-printing-001
09.11.2020
News, Media Releases

REGENHU opens new office in Edina, Minnesota

Villaz-St-Pierre, Switzerland
REGENHU, a leading, global provider of bioprinting technologies, announced today the opening of its office in Minnesota, United States, establishing its presence in North America. This company’s first office in the US, located in Medical Alley, Minnesota, officially opened its doors last Monday. It will serve as the central hub for delivering cutting-edge bioprinting solutions […]
11.11.2019
REGENHU-SWITZERLAND-3DBIOPRINTING-SimonMacKenzie-CEO-003
11.11.2019
News

REGENHU LTD appoints Simon MacKenzie as new CEO

SWISS INVESTMENT GROUP NIVALIS GROUP AND REGENHU’S BOARD OF DIRECTORS HAVE UNANIMOUSLY DECIDED TO APPOINT SIMON MACKENZIE AS THE NEW CEO OF REGENHU S.A., STARTING 11 NOVEMBER 2019.
Simon MacKenzie, 49 years old and a UK citizen, has a wealth of experience in biotech and Med Tech.